Cargando…
Dendrimer antibody conjugate to target and image HER-2 overexpressing cancer cells
Although many breast and lung cancers overexpress human epidermal growth factor receptor-2 (HER-2), no methods currently exist for effective and early detection of HER-2-positive cancers. To address this issue, we designed and synthesized dendrimer-based novel nano-imaging agents that contain gold n...
Autores principales: | Otis, James B., Zong, Hong, Kotylar, Alina, Yin, Anna, Bhattacharjee, Somnath, Wang, Han, James R., Baker, Wang, Su He |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094978/ https://www.ncbi.nlm.nih.gov/pubmed/27144519 http://dx.doi.org/10.18632/oncotarget.9081 |
Ejemplares similares
-
Functionalized nanoparticles with targeted antibody to enhance imaging of breast cancer in vivo
por: Chen, Jesse S., et al.
Publicado: (2020) -
Multicomponent Conjugates of Anticancer Drugs and Monoclonal Antibody with PAMAM Dendrimers to Increase Efficacy of HER-2 Positive Breast Cancer Therapy
por: Marcinkowska, Monika, et al.
Publicado: (2019) -
Antibody–PROTAC Conjugates Enable HER2-Dependent
Targeted Protein Degradation of BRD4
por: Maneiro, María, et al.
Publicado: (2020) -
Multivalent Conjugation of Antibody to Dendrimers for the Enhanced Capture and Regulation on Colon Cancer Cells
por: Xie, Jingjing, et al.
Publicado: (2015) -
Design and Evaluation of Tumor-Specific Dendrimer Epigenetic Therapeutics
por: Zong, Hong, et al.
Publicado: (2015)